DENTSPLY SIRONA INC. (NASDAQ:XRAY) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

DENTSPLY SIRONA INC. (NASDAQ:XRAY) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective October 10, 2017, Mr. Jonathan I. Friedman, the Senior Vice President, Secretary and General Counsel of DENTSPLY SIRONA Inc. (the “Company”), tendered his resignation from employment with the Company, which resignation was accepted by the Company effective October 11, 2017. The Company will provide Mr. Friedman with the benefits available under his employment agreement in the case of a termination by the Company without cause.

Item 8.01 Other Events.

On October 16, 2017, the Company issued a press release announcing the appointments of Nicholas Alexos as Executive Vice President and Chief Administrative Officer of the Company and KeithEbling as Executive Vice President, General Counsel and Secretary of the Company, and the resignation of Mr. Friedman. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d)

Exhibits

Press Release, issued October 16, 2017


DENTSPLY SIRONA Inc. Exhibit
EX-99.1 2 ex99-1.htm EXHIBIT 99.1 – PRESS RELEASE Dentsply Sirona Announces Additions to Executive Leadership Team • Nicholas Alexos Appointed EVP,…
To view the full exhibit click here

About DENTSPLY SIRONA INC. (NASDAQ:XRAY)

DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. The Company’s segments include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses. The Company’s principal product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company distributes its products in over 120 countries. It offers brands, such as ANKYLOS, AQUASIL ULTRA, ARTICADENT, XIVE, ORAQIX, XYLOCAINE, ZHERMACK, IN-OVATION, LOFRIC, MAILLEFER, MIDWEST, NUPRO, ORIGO, OSSEOSPEED and PALODENT PLUS.